Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP624444.RAnyYms7rA4jD8_3S5Wx4DUxlTYC-xlz7ubbTwyyiijj0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP624444.RAnyYms7rA4jD8_3S5Wx4DUxlTYC-xlz7ubbTwyyiijj0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP624444.RAnyYms7rA4jD8_3S5Wx4DUxlTYC-xlz7ubbTwyyiijj0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP624444.RAnyYms7rA4jD8_3S5Wx4DUxlTYC-xlz7ubbTwyyiijj0130_provenance.
- NP624444.RAnyYms7rA4jD8_3S5Wx4DUxlTYC-xlz7ubbTwyyiijj0130_assertion description "[Selective inhibition of PI3K? (p110?) by GS-1101 has emerged as a promising therapy in chronic lymphocytic leukemia and indolent lymphomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP624444.RAnyYms7rA4jD8_3S5Wx4DUxlTYC-xlz7ubbTwyyiijj0130_provenance.
- NP624444.RAnyYms7rA4jD8_3S5Wx4DUxlTYC-xlz7ubbTwyyiijj0130_assertion evidence source_evidence_literature NP624444.RAnyYms7rA4jD8_3S5Wx4DUxlTYC-xlz7ubbTwyyiijj0130_provenance.
- NP624444.RAnyYms7rA4jD8_3S5Wx4DUxlTYC-xlz7ubbTwyyiijj0130_assertion SIO_000772 23676220 NP624444.RAnyYms7rA4jD8_3S5Wx4DUxlTYC-xlz7ubbTwyyiijj0130_provenance.
- NP624444.RAnyYms7rA4jD8_3S5Wx4DUxlTYC-xlz7ubbTwyyiijj0130_assertion wasDerivedFrom befree-20150227 NP624444.RAnyYms7rA4jD8_3S5Wx4DUxlTYC-xlz7ubbTwyyiijj0130_provenance.
- NP624444.RAnyYms7rA4jD8_3S5Wx4DUxlTYC-xlz7ubbTwyyiijj0130_assertion wasGeneratedBy ECO_0000203 NP624444.RAnyYms7rA4jD8_3S5Wx4DUxlTYC-xlz7ubbTwyyiijj0130_provenance.
- befree-20150227 importedOn "2015-02-27" NP624444.RAnyYms7rA4jD8_3S5Wx4DUxlTYC-xlz7ubbTwyyiijj0130_provenance.